Beta Bionics, Inc. (BBNX) PT Lowered to $30.40 at Ladenburg Thalmann

July 30, 2026 7:36 AM

Ladenburg Thalmann analyst Jeffrey Cohen lowered the price target on Beta Bionics, Inc. (NASDAQ: BBNX) to $30.40 (from $32.00) while maintaining a Buy rating.

No results found